Evidence map›Paper›PMID 28161745›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Serious fungal infections in Canada.

S F Dufresne, D C Cole, D W Denning, D C Sheppard

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sero-Epidemiology ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Interactions betweenFrontiers in microbiology · 2022
    Review
  8. Proteomics ofInternational journal of molecular sciences · 2021
    Review
  9. Article
  10. Recent Trends in the Epidemiology of Fungal Infections.Infectious disease clinics of North America · 2021
    Review
  11. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
  12. Endemic and Other Dimorphic Mycoses in The Americas.Journal of fungi (Basel, Switzerland) · 2021
    Review
  13. Disseminated cryptococcal infection in a patient with a remote renal transplant.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
  14. Article
  15. Update on invasive fungal infections in the Middle Eastern and North African region.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Review
  16. Article
  17. Review
  18. Ulcerated nodule in a 50-year old man who underwent lung transplantation.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

S F DufresneDepartment of Infectious Diseases and Medical Microbiology, Maisonneuve-Rosemont Hospital Research Center, Université de Montréal, Montréal, Canada. sf.dufresne@umontreal.ca.
D C ColeDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
D W DenningThe National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
D C SheppardDepartment of Microbiology and Immunology and Department of Medicine, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, McGill University, Montréal, Canada.
Hôpital Maisonneuve-Rosemont · CAManchester Academic Health Science Centre · GBMcGill University Health Centre · CAPublic Health Ontario · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are currently no nationwide epidemiological data on fungal infections in Canada. We estimated the burden of serious fungal diseases using literature review and modeling, as per a methodology previously described by the LIFE program ( http://www.LIFE-worldwide.org ). Among the population of Canada (35.5 million in 2014), it was estimated that approximately 1.8% are affected by a serious fungal infection. Recurrent vulvovaginal candidiasis, severe asthma with fungal sensitization, and allergic bronchopulmonary aspergillosis are the most frequent infections, with population prevalences of 498,688 (1403/100,000), 73,344 (206/100,000), and 61,854 (174/100,000) cases, respectively. Over 3000 invasive fungal infections are estimated to occur annually, with incidences of 2068 cases (5.8/100,000) of invasive candidiasis, 566 cases (1.6/100,000) of invasive aspergillosis, 252 cases (0.71/100,000) of Pneumocystis pneumonia, 99 cases (0.28/100,000) of endemic mycoses, and 63 cases (0.18/100,000) of cryptococcosis. These estimates warrant validation through more formal epidemiological studies in Canada.

Indexed as

AdolescentAdultAgedCanadaChildChild, PreschoolComorbidityFemaleHumansIncidenceInfantInfant, NewbornMaleMiddle AgedMycosesPrevalence

Identifiers

PMID28161745
OpenAlexW2584493087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.